Omnia SanaPlant Comparison
Greater Celandine vs Wild Yam
A side-by-side comparison of two medicinal plants — every documented constituent, action, use, safety note and cited source, assembled automatically from the Omnia Sana database.
At a glance
Greater Celandine and Wild Yam: they share 9 indicated uses (arthritis / joint pain, back pain, cancer (anticancer research), …); 4 pharmacological actions in common.
Evidence face-off — shared uses
| Condition | Greater Celandine | Wild Yam | Verdict |
|---|---|---|---|
| Arthritis / joint pain | 1/10 | 2/10 | Comparable evidence |
| Back pain | 1/10 | 2/10 | Comparable evidence |
| Cancer (anticancer research) | 2/10 | 2/10 | Comparable evidence |
| Headache | 1/10 | 2/10 | Comparable evidence |
| Inflammation (general) | 1/10 | 2/10 | Comparable evidence |
| Menstrual cramps | 1/10 | 2/10 | Comparable evidence |
| Muscle spasm | 1/10 | 2/10 | Comparable evidence |
| Pain (general) | 1/10 | 2/10 | Comparable evidence |
| Skin irritation | 1/10 | 2/10 | Comparable evidence |
Evidence scores (1–10) are computed from the tier of each cited source. “Comparable” means the two scores are within one point. Follow a score to its detailed sources.
Key Constituents
The biologically active and toxicologically important constituents.
Diosgenin is an industrial precursor for making steroid hormones in the laboratory, but it is NOT converted into hormones in the human body. Oral bioavailability of diosgenin is low; in animal studies orally administered diosgenin restored skin thickness in ovariectomised mice and lowered blood lipids.
Pharmacological Actions
Anti-inflammatory, antimicrobial and analgesic (preclinical)
Antispasmodic / choleretic bitter for upper-abdominal and biliary dyspepsia (indigestion, bloating, cramping) - oral use now restricted for safety
Antispasmodic / choleretic bitter for upper-abdominal and biliary dyspepsia (indigestion, bloating, cramping) - oral use now restricted for safety
Antispasmodic / analgesic for menstrual cramps and muscle spasm (antinociceptive in animal models)
Anti-inflammatory for joint and inflammatory pain
Antispasmodic / analgesic for menstrual cramps and muscle spasm (antinociceptive in animal models)
Traditional & Indicated Uses
inferred from anti-inflammatory action
Antispasmodic / choleretic bitter for upper-abdominal and biliary dyspepsia (indigestion, bloating, cramping) - oral use now restricted for safety
inferred from anticancer action
Antispasmodic / choleretic bitter for upper-abdominal and biliary dyspepsia (indigestion, bloating, cramping) - oral use now restricted for safety
inferred from antimicrobial action
inferred from anti-inflammatory action
inferred from antispasmodic action
inferred from anti-inflammatory action
inferred from anti-inflammatory action
inferred from anticancer action
inferred from anti-inflammatory action
Traditional support for menopausal symptoms (see safety note - it does NOT act as a natural progesterone) - a placebo-controlled crossover RCT of topical wild yam cream found little effect on menopausal symptoms, lipids or hormones
Antispasmodic / analgesic for menstrual cramps and muscle spasm (antinociceptive in animal models)
Antispasmodic / analgesic for menstrual cramps and muscle spasm (antinociceptive in animal models)
Anti-inflammatory for joint and inflammatory pain
inferred from anti-inflammatory action
Safety, Cautions & Contraindications
SERIOUS: oral greater celandine can cause acute idiosyncratic liver injury (hepatocellular hepatotoxicity with jaundice). Multiple reported cases - dozens of herb-induced liver injury reports in the literature, with continuing recent case reports - led regulators to restrict or suspend oral products. Do not take internally if you have any liver disease, and stop immediately and seek care at any sign of liver problems (jaundice, dark urine, upper-abdominal pain).
IMPORTANT myth-bust: wild yam / diosgenin is NOT converted into progesterone or DHEA in the body, so it does not work as a 'natural progesterone' - claims to that effect are incorrect. Consistent with this, a randomized placebo-controlled crossover trial of topical wild yam cream found no significant change in symptoms, serum/salivary progesterone, oestradiol, FSH or lipids.
Generally well tolerated orally (no acute or subchronic toxicity in animal studies); large doses may cause nausea or vomiting. Avoid medicinal doses in pregnancy and breastfeeding and in hormone-sensitive conditions as a precaution.
External Ids
Botanical Description
Branching perennial herb with soft, brittle, hairy stems that exude a distinctive bright orange-yellow latex (sap) when cut or broken. The leaves are deeply lobed, pale bluish-green beneath, giving a delicate, almost fern-like appearance. Small, four-petalled, bright yellow flowers are borne in loose umbel-like clusters.[4]
Twining, herbaceous perennial vine with heart-shaped leaves arising from a knotty, woody, cinnamon-brown rhizome ('root'). Small, inconspicuous greenish-yellow flowers are borne on separate male and female plants, followed on female plants by small three-winged seed capsules.[10]
Habitat
Grows in shaded, nutrient-rich ground - hedgerows, walls, waste ground and woodland edges, often near old buildings; native to Europe and Western Asia and naturalised in North America.[4]
Native to woodland edges, thickets and fence rows of eastern North America, growing over shrubs and fences in moist, rich soil.[10]
Harvesting
The flowering aerial parts are cut in spring to summer; the fresh orange latex is collected by breaking a stem or leaf as needed for topical (wart) use. Given the documented hepatotoxicity of oral preparations, harvesting for internal use is not recommended.[4]
The knotty rhizome is dug in autumn once the aerial vine has died back, then cleaned and dried.
Traditional Uses
Greater celandine has a long European folk history, reflected in its name 'tetterwort', as a topical remedy for warts and skin blemishes (the fresh orange latex dabbed directly on), and internally as a bitter choleretic digestive remedy for biliary and upper-abdominal dyspepsia - though oral use is now medically restricted because of documented liver injury.[4]
Wild yam root has a Native American and Eclectic-medicine history as an antispasmodic remedy for colic, menstrual cramps and rheumatic joint pain (reflected in the old names 'colic root' and 'rheumatism root'); despite a persistent modern myth, its diosgenin content is not converted into progesterone or other hormones in the human body.[10]
Preparations
Fresh orange latex from a broken stem dabbed directly onto warts, the classic external folk use; kept well away from eyes, mucous membranes and broken skin.
Historically taken as an infusion or tincture for biliary dyspepsia, but oral use is now restricted in several jurisdictions due to hepatotoxicity risk and should only be considered under professional supervision, if at all.
Dosage
Because of a documented risk of acute liver injury, no internal dose is given here; oral use should be avoided, especially by anyone with liver disease, and any sign of jaundice, dark urine or upper-abdominal pain warrants immediate medical attention. Educational reference only, not a prescription.
Not documented
References
Lookalikes Review
References & Sources
- Li, X.L., Sun, Y.P., Wang, M., Wang, Z.B. and Kuang, H.X (2024) 'Alkaloids in Chelidonium majus L.: a review of its phytochemistry, pharmacology and toxicology', Frontiers in Pharmacology, 15, pp. 1440979. doi:10.3389/fphar.2024.1440979 Traditional / reference
https://doi.org/10.3389/fphar.2024.1440979 - Koriem, K.M.M., Arbid, M.S. and Asaad, G.F (2012) 'Chelidonium majus leaves methanol extract and its chelidonine alkaloid ingredient reduce cadmium-induced nephrotoxicity in rats', Journal of Natural Medicines, 67(1), pp. 159-167. doi:10.1007/s11418-012-0667-6 Preclinical
https://doi.org/10.1007/s11418-012-0667-6 - Nawrot, R (2017) 'Defense-related Proteins from Chelidonium majus L. as Important Components of its Latex', Current Protein & Peptide Science, 18(8), pp. 864-880. doi:10.2174/1389203718666170406124013 Traditional / reference
https://doi.org/10.2174/1389203718666170406124013 - Gilca, M., Gaman, L., Panait, E., Stoian, I. and Atanasiu, V (2010) 'Chelidonium majus - an integrative review: traditional knowledge versus modern findings', Forschende Komplementarmedizin. doi:10.1159/000321397 Traditional / reference
https://doi.org/10.1159/000321397 - Popovic, A., Deljanin, M., Popovic, S., Todorovic, D., Djurdjevic, P., Matic, S., Stankovic, M., Avramovic, D. and Baskic, D (2021) 'Chelidonium majus crude extract induces activation of peripheral blood mononuclear cells and enhances their cytotoxic effect toward HeLa cells', International Journal of Environmental Health Research, 32(7), pp. 1554-1566. doi:10.1080/09603123.2021.1897534 Preclinical
https://doi.org/10.1080/09603123.2021.1897534 - Shen, L., Lee, S.A., Joo, J.C., Hong, E., Cui, Z.Y., Jo, E., Park, S.J. and Jang, H.J (2022) 'Chelidonium majus induces apoptosis of human ovarian cancer cells via ATF3-mediated regulation of Foxo3a by Tip60', Journal of Microbiology and Biotechnology, 32(4), pp. 493-503. doi:10.4014/jmb.2109.09030 Preclinical
https://doi.org/10.4014/jmb.2109.09030 - Deljanin, M., Nikolic, M., Baskic, D., Todorovic, D., Djurdjevic, P., Zaric, M., Stankovic, M., Todorovic, M., Avramovic, D. and Popovic, S (2016) 'Chelidonium majus crude extract inhibits migration and induces cell cycle arrest and apoptosis in tumor cell lines', Journal of Ethnopharmacology, 190, pp. 362-371. doi:10.1016/j.jep.2016.06.056 Preclinical
https://doi.org/10.1016/j.jep.2016.06.056 - Warowicka, A., Qasem, B., Dera-Szymanowska, A., Wolun-Cholewa, M., Florczak, P., Horst, N., Napierala, M., Szymanowski, K., Popenda, L., Bartkowiak, G., Florek, E., Gozdzicka-Jozefiak, A. and Mlynarz, P (2021) 'Effect of protoberberine-rich fraction of Chelidonium majus L. on endometriosis regression', Pharmaceutics, 13(7), pp. 931. doi:10.3390/pharmaceutics13070931 Preclinical
https://doi.org/10.3390/pharmaceutics13070931 - Kadan, G., Gozler, T. and Hesse, M (1992) '(+)-Norchelidonine from Chelidonium majus', Planta Medica, 58(5), pp. 477. doi:10.1055/s-2006-961523 Preclinical
https://doi.org/10.1055/s-2006-961523 - Musidlak, O., Warowicka, A., Broniarczyk, J., Adamczyk, D., Gozdzicka-Jozefiak, A. and Nawrot, R (2022) 'The activity of Chelidonium majus L. latex and its components on HPV reveal insights into the antiviral molecular mechanism', International Journal of Molecular Sciences, 23(16), pp. 9241. doi:10.3390/ijms23169241 Preclinical
https://doi.org/10.3390/ijms23169241 - Zhang, W., You, C., Wang, C., Fan, L., Wang, Y., Su, Y., Deng, Z. and Du, S (2014) 'One new alkaloid from Chelidonium majus L', Natural Product Research, 28(21), pp. 1873-1878. doi:10.1080/14786419.2014.953497 Preclinical
https://doi.org/10.1080/14786419.2014.953497 - Capistrano I, R., Wouters, A., Lardon, F., Gravekamp, C., Apers, S. and Pieters, L (2015) 'In vitro and in vivo investigations on the antitumour activity of Chelidonium majus', Phytomedicine, 22(14), pp. 1279-1287. doi:10.1016/j.phymed.2015.10.013 Preclinical
https://doi.org/10.1016/j.phymed.2015.10.013 - Teschke, R., Frenzel, C., Glass, X., Schulze, J. and Eickhoff, A (2012) 'Greater Celandine hepatotoxicity: a clinical review', Annals of Hepatology. doi:10.1016/s1665-2681(19)31408-5 Clinical study
https://doi.org/10.1016/s1665-2681(19)31408-5 - Ciornolutchii, V., Ismaiel, A., Sabo, C.M., Al Hajjar, N., Seicean, A. and Dumitrascu, D.L (2024) 'A Hidden Cause of Hypertransaminasemia: Liver Toxicity Caused by Chelidonium Majus L. Report of Two Cases of Herb-Induced Liver Injury and Literature Review', American Journal of Therapeutics, 31(4), pp. e382--e387. doi:10.1097/MJT.0000000000001708 Clinical study
https://doi.org/10.1097/MJT.0000000000001708
- Depypere, H.T. and Comhaire, F.H (2013) 'Herbal preparations for the menopause: beyond isoflavones and black cohosh', Maturitas, 77(2), pp. 191-194. doi:10.1016/j.maturitas.2013.11.001 Traditional / reference
https://doi.org/10.1016/j.maturitas.2013.11.001 - Cai, B., Zhang, Y., Wang, Z., Xu, D. et al (2020) 'Therapeutic Potential of Diosgenin and Its Major Derivatives against Neurological Diseases: Recent Advances', Oxidative Medicine and Cellular Longevity, 2020, pp. 3153082. doi:10.1155/2020/3153082 Traditional / reference
https://doi.org/10.1155/2020/3153082 - Raj, P.S., Bergfeld, W.F., Belsito, D.V., Cohen, D.E. et al (2023) 'Safety Assessment of Dioscorea Villosa (Wild Yam) Root Extract as Used in Cosmetics', International Journal of Toxicology, 42(3_suppl), pp. 29S-31S. doi:10.1177/10915818231204230 Traditional / reference
https://doi.org/10.1177/10915818231204230 - Dong, S., Nikolic, D., Simmler, C., Qiu, F., van Breemen, R.B., Soejarto, D.D., Pauli, G.F. and Chen, S (2012) 'Diarylheptanoids from Dioscorea villosa (wild yam)', Journal of Natural Products, 75(12), pp. 2168-2177. doi:10.1021/np300603z Preclinical
https://doi.org/10.1021/np300603z - Dong, S., Cai, G., Napolitano, J.G., Nikolic, D., Lankin, D.C., McAlpine, J.B., van Breemen, R.B., Soejarto, D.D., Pauli, G.F. and Chen, S (2013) 'Lipidated steroid saponins from Dioscorea villosa (wild yam)', Fitoterapia, 91, pp. 113-124. doi:10.1016/j.fitote.2013.07.018 Preclinical
https://doi.org/10.1016/j.fitote.2013.07.018 - Wojcikowski, K., Wohlmuth, H., Johnson, D.W. and Gobe, G (2008) 'Dioscorea villosa (wild yam) induces chronic kidney injury via pro-fibrotic pathways', Food and Chemical Toxicology, 46(9), pp. 3122-3131. doi:10.1016/j.fct.2008.06.090 Preclinical
https://doi.org/10.1016/j.fct.2008.06.090 - Mazzio, E., Almalki, A., Darling-Reed, S.F. and Soliman, K.F.A (2021) 'Effects of wild yam root (Dioscorea villosa) extract on the gene expression profile of triple-negative breast cancer cells', Cancer Genomics & Proteomics, 18(6), pp. 735-755. doi:10.21873/cgp.20294 Preclinical
https://doi.org/10.21873/cgp.20294 - Ali, Z., Smillie, T.J. and Khan, I.A (2013) 'Cholestane steroid glycosides from the rhizomes of Dioscorea villosa (wild yam)', Carbohydrate Research, 370, pp. 86-91. doi:10.1016/j.carres.2012.12.022 Preclinical
https://doi.org/10.1016/j.carres.2012.12.022 - Manda, V.K., Avula, B., Ali, Z., Wong, Y., Smillie, T.J., Khan, I.A. and Khan, S.I (2013) 'Characterization of in vitro ADME properties of diosgenin and dioscin from Dioscorea villosa', Planta Medica, 79(15), pp. 1421-1428. doi:10.1055/s-0033-1350699 Preclinical
https://doi.org/10.1055/s-0033-1350699 - Lima, C.M., Lima, A.K., Melo, M.G.D., Serafini, M.R., Oliveira, D.L., de Almeida, E.B., Barreto, R.S.S., Nogueira, P.C., Moraes, V.R.S., Oliveira, E.R.A., de Albuquerque, R.L.C., Quintans-Junior, L.J. and Araujo, A.A.S (2013) 'Bioassay-guided evaluation of Dioscorea villosa - an acute and subchronic toxicity, antinociceptive and anti-inflammatory approach', BMC Complementary and Alternative Medicine. doi:10.1186/1472-6882-13-195 Preclinical
https://doi.org/10.1186/1472-6882-13-195 - Avula, B., Wang, Y., Wang, M., Ali, Z., Smillie, T.J., Zweigenbaum, J. and Khan, I.A (2014) 'Characterization of steroidal saponins from Dioscorea villosa and D. cayenensis using ultrahigh performance liquid chromatography/electrospray ionization quadrupole time-of-flight mass spectrometry', Planta Medica, 80(4), pp. 321-329. doi:10.1055/s-0033-1360330 Preclinical
https://doi.org/10.1055/s-0033-1360330 - Siddiqui, M.A., Ali, Z., Chittiboyina, A.G. and Khan, I.A (2018) 'Hepatoprotective effect of steroidal glycosides from Dioscorea villosa on hydrogen peroxide-induced hepatotoxicity in HepG2 cells', Frontiers in Pharmacology, 9, pp. 797. doi:10.3389/fphar.2018.00797 Preclinical
https://doi.org/10.3389/fphar.2018.00797 - Hayes, P.Y., Lambert, L.K., Lehmann, R., Penman, K., Kitching, W. and De Voss, J.J (2007) 'Complete 1H and 13C assignments of the four major saponins from Dioscorea villosa (wild yam)', Magnetic Resonance in Chemistry, 45(11), pp. 1001-1005. doi:10.1002/mrc.2071 Preclinical
https://doi.org/10.1002/mrc.2071 - Okawara, M. and Tokudome, Y. and Todo, H. and Sugibayashi, K. and Hashimoto, F (2013) 'Enhancement of diosgenin distribution in the skin by cyclodextrin complexation following oral administration', Biological & Pharmaceutical Bulletin, 36(1), pp. 36--40. doi:10.1248/bpb.b12-00467 Preclinical
https://doi.org/10.1248/bpb.b12-00467 - Komesaroff, P.A., Black, C.V., Cable, V. and Sudhir, K (2001) 'Effects of wild yam extract on menopausal symptoms, lipids and sex hormones in healthy menopausal women', Climacteric, 4(2), pp. 144--150. doi:10.1080/cmt.4.2.144.150 Randomized trial
https://doi.org/10.1080/cmt.4.2.144.150
Generated automatically from the Omnia Sana plant database and its cited sources. For educational purposes only — not medical advice. Always consult a qualified practitioner before using medicinal plants.